Inside Immatics / Scientific Advisory Board

Scientific Advisory Board

Immatics’ Scientific Advisory Board is made up of pioneering scientists with
expertise ranging across areas such as immuno-oncology, adoptive cell therapies,
clinical oncology and cancer biology.

Cassian Yee, M.D.

MD Anderson Cancer Center US
Christoph Huber, Ph.D.

Johannes Gutenberg University Germany
Crystal Mackall, M.D.

Stanford University US
Gwendolyn Binder, Ph.D.

Cabaletta Bio US
Hans-Georg Rammensee, Ph.D.

Eberhard Karls University Germany
Hidde Ploegh, Ph.D.

Boston Children’s Hospital US
Patrick Hwu, M.D.

The University of Texas MD Anderson Cancer Center US
Roland Kontermann, Ph.D.

University of Stuttgart Germany